Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II BeEAM conditioning regimen before autologous stem cell transplantation in refractory/relapsed aggressive B-cell non-Hodgkin lymphoma
2011-001246-14Phase 2Completed
- Sponsor
- San Salvatore Hospital of L'Aquila
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in non-Hodgkin lymphoma (NHL), sponsored by San Salvatore Hospital of L'Aquila. Primary endpoint: 1-year complete remission rate. Started Mar 2012; status: completed.
02
Drugs
bendamustine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on 2011-001246-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001246-14.